Your browser doesn't support javascript.
loading
Potassium Channels as Therapeutic Targets in Pulmonary Arterial Hypertension.
Redel-Traub, Gabriel; Sampson, Kevin J; Kass, Robert S; Bohnen, Michael S.
Affiliation
  • Redel-Traub G; Department of Medicine, Columbia University Irving Medical Center, New York, NY 10032, USA.
  • Sampson KJ; Department of Molecular Pharmacology and Therapeutics, Columbia University Irving Medical Center, New York, NY 10032, USA.
  • Kass RS; Department of Molecular Pharmacology and Therapeutics, Columbia University Irving Medical Center, New York, NY 10032, USA.
  • Bohnen MS; Division of Cardiology, Department of Medicine, Columbia University Irving Medical Center, New York, NY 10032, USA.
Biomolecules ; 12(10)2022 Sep 22.
Article in En | MEDLINE | ID: mdl-36291551

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Potassium Channels, Tandem Pore Domain / Potassium Channels, Voltage-Gated / Channelopathies / Pulmonary Arterial Hypertension / Hypertension, Pulmonary Limits: Humans Language: En Journal: Biomolecules Year: 2022 Type: Article Affiliation country: United States

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Potassium Channels, Tandem Pore Domain / Potassium Channels, Voltage-Gated / Channelopathies / Pulmonary Arterial Hypertension / Hypertension, Pulmonary Limits: Humans Language: En Journal: Biomolecules Year: 2022 Type: Article Affiliation country: United States